Cargando…
Vascular Changes in Bleomycin-Induced Scleroderma
Systemic sclerosis (SSc) is characterized by vascular injury, immunological abnormalities, and fibrosis of the skin as well as various internal organs. Vascular impairment is the early manifestation and plays a fundamental role in the pathogenesis of SSc. Recent studies suggest that complex interact...
Autores principales: | Yamamoto, Toshiyuki, Katayama, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199103/ https://www.ncbi.nlm.nih.gov/pubmed/22028717 http://dx.doi.org/10.1155/2011/270938 |
Ejemplares similares
-
A case of bleomycin-induced scleroderma.
por: Kim, K. H., et al.
Publicado: (1996) -
Connective tissue growth factor is induced in bleomycin-induced skin scleroderma
por: Liu, Shangxi, et al.
Publicado: (2009) -
Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma
por: Park, Gyu-Tae, et al.
Publicado: (2021) -
Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice
por: Song, Yinghua, et al.
Publicado: (2013) -
Formyl Peptide Receptor 2 Activation Ameliorates Dermal Fibrosis and Inflammation in Bleomycin-Induced Scleroderma
por: Park, Gyu Tae, et al.
Publicado: (2019)